PVTT is associated with aggressive tumour biology, characterised by high tumour grade, significant tumour burden (both in number and size of lesions), elevated serum tumour markers such as alpha‐fetoprotein (AFP), impaired liver function (as indicated by abnormal liver function tests) and poor patient performance status. The gene discussed is AFP; the disease is neoplasm.